For Clinics

B2B resources and operational guidance for ketamine and psychedelic clinic owners.

FDA Faces a Core Problem in Psychedelic Trials: Everyone Knows Who Got the Drug

In many studies, participants can tell when they received the active drug. That makes these trials functionally open label.

Read More

How to Get Your Ketamine Clinic Cited by ChatGPT, Perplexity, and Gemini

Patients are asking AI tools for ketamine clinic recommendations — and most clinics are invisible. Here are the 6 ranking

Read More

Explore Psychedelic Therapy Regions